Stay updated on Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a phase 2 trial for Basal Cell Carcinoma and the addition of new identifiers and collaborators. Notably, the study now allows patients from Arm A to crossover to Arm B or C.SummaryDifference54%
Stay in the know with updates to Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.